1. The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis
    Yi Dong et al, 2013, Pathology - Research and Practice CrossRef
  2. Axillary Skip Metastases and the False-Negative Rate of Sentinel Lymph Node Biopsy in Patients With Breast Cancer Are Related to Negative ALDH-1 Expression and Ki-67 Expression
    Woo Gyeong Kim et al, 2017, International Journal of Surgical Pathology CrossRef
  3. Prognosis assessment of CD44+/CD24− in breast cancer patients: a systematic review and meta-analysis
    Jingjing Gu et al, 2022, Archives of Gynecology and Obstetrics CrossRef
  4. Molecular biomarkers screened by next-generation RNA sequencing for non-sentinel lymph node status prediction in breast cancer patients with metastatic sentinel lymph nodes
    Feng Liang et al, 2015, World Journal of Surgical Oncology CrossRef
  5. POU5F1/Oct-4 expression in breast cancer tissue is significantly associated with non-sentinel lymph node metastasis
    Shouliang Cai et al, 2016, BMC Cancer CrossRef
  6. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
    Wenzhe Li et al, 2017, Scientific Reports CrossRef
  7. The positive non‐sentinel status is not the main decisional factor for chemotherapy assignment in breast cancer with micrometastatic disease in the sentinel lymph node
    Chafika Mazouni et al, 2012, Journal of Surgical Oncology CrossRef
  8. Cryoimmunology: Opportunities and challenges in biomedical science and practice
    Nikolai N. Korpan et al, 2021, Cryobiology CrossRef
  9. Aldehyde dehydrogenase 1 (ALDH1) immunostaining in axillary lymph node metastases is an independent prognostic factor in ALDH1-positive breast cancer
    Xin Guan et al, 2021, Journal of International Medical Research CrossRef
  10. Cannabidiol Suppresses Angiogenesis and Stemness of Breast Cancer Cells by Downregulation of Hypoxia-Inducible Factors-1α
    Min Jee Jo et al, 2021, Cancers CrossRef
  11. Breast Cancer Stem Cells with Tumor- versus Metastasis-Initiating Capacities Are Modulated by TGFBR1 Inhibition
    Flavia Fico et al, 2019, Stem Cell Reports CrossRef